Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 8 studies | 22% ± 5% | |
glutamatergic neuron | 6 studies | 48% ± 22% | |
interneuron | 5 studies | 37% ± 18% | |
astrocyte | 5 studies | 27% ± 11% | |
GABAergic neuron | 5 studies | 41% ± 12% | |
neuron | 4 studies | 31% ± 7% | |
myeloid cell | 4 studies | 20% ± 6% | |
epithelial cell | 4 studies | 26% ± 11% | |
oligodendrocyte | 4 studies | 25% ± 7% | |
endothelial cell | 3 studies | 29% ± 13% | |
oligodendrocyte precursor cell | 3 studies | 22% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 35% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 969.88 | 459 / 459 | 100% | 15.55 | 1116 / 1118 |
intestine | 100% | 778.61 | 966 / 966 | 100% | 11.97 | 525 / 527 |
esophagus | 100% | 834.22 | 1439 / 1445 | 100% | 12.68 | 183 / 183 |
brain | 99% | 1206.94 | 2623 / 2642 | 100% | 14.91 | 704 / 705 |
kidney | 100% | 1010.31 | 89 / 89 | 99% | 9.65 | 892 / 901 |
ovary | 98% | 629.85 | 177 / 180 | 100% | 10.68 | 430 / 430 |
prostate | 99% | 649.69 | 243 / 245 | 99% | 9.49 | 497 / 502 |
skin | 100% | 1896.57 | 1809 / 1809 | 98% | 12.94 | 463 / 472 |
stomach | 99% | 702.96 | 354 / 359 | 99% | 11.43 | 284 / 286 |
uterus | 100% | 773.41 | 170 / 170 | 98% | 8.91 | 449 / 459 |
bladder | 100% | 817.14 | 21 / 21 | 97% | 9.94 | 488 / 504 |
liver | 100% | 1854.51 | 226 / 226 | 97% | 9.91 | 392 / 406 |
thymus | 100% | 778.19 | 651 / 653 | 96% | 8.77 | 581 / 605 |
lung | 96% | 700.14 | 553 / 578 | 100% | 11.98 | 1154 / 1155 |
pancreas | 97% | 687.33 | 319 / 328 | 98% | 6.88 | 174 / 178 |
adrenal gland | 86% | 398.57 | 223 / 258 | 66% | 2.82 | 151 / 230 |
adipose | 100% | 1083.50 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 2495.85 | 803 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 9.88 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.26 | 1 / 1 |
blood vessel | 99% | 766.15 | 1325 / 1335 | 0% | 0 | 0 / 0 |
spleen | 99% | 609.10 | 239 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 13.09 | 79 / 80 |
lymph node | 0% | 0 | 0 / 0 | 97% | 9.19 | 28 / 29 |
heart | 90% | 580.61 | 772 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 58% | 709.55 | 538 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006518 | Biological process | peptide metabolic process |
GO_1902809 | Biological process | regulation of skeletal muscle fiber differentiation |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0006508 | Biological process | proteolysis |
GO_0006111 | Biological process | regulation of gluconeogenesis |
GO_0005758 | Cellular component | mitochondrial intermembrane space |
GO_0005829 | Cellular component | cytosol |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0042277 | Molecular function | peptide binding |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | NLN |
Protein name | Neurolysin, mitochondrial (EC 3.4.24.16) (Microsomal endopeptidase) (Mitochondrial oligopeptidase M) (Neurotensin endopeptidase) Neurolysin Neurolysin, mitochondrial (EC 3.4.24.16) (Angiotensin-binding protein) (Microsomal endopeptidase) (MEP) (Mitochondrial oligopeptidase M) (Neurotensin endopeptidase) |
Synonyms | AGTBP KIAA1226 |
Description | FUNCTION: Hydrolyzes oligopeptides such as neurotensin, bradykinin and dynorphin A (By similarity). Acts as a regulator of cannabinoid signaling pathway by mediating degradation of hemopressin, an antagonist peptide of the cannabinoid receptor CNR1 (By similarity). . |
Accessions | D6R9Y0 H0YAF7 ENST00000380985.10 ENST00000509935.2 ENST00000514991.5 ENST00000502464.5 E9PCB6 Q9BYT8 ENST00000511299.5 H0YAK4 |